Tinzaparin is an antithrombotic drug in the heparin group. It is a low molecular weight heparin (LMWH) marketed as Innohep worldwide. It has been approved by the U.S. Food and Drug Administration (FDA) for once daily treatment and prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism (PE).
It can be given subcutaneously by syringe, or intravenously.
It was manufactured by Leo pharmaceutical company, who withdrew the product from the US in 201...
* May have multiple approval dates, manufacturers, or labelers.